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Direct comparison of methionine 
restriction with leucine restriction 
on the metabolic health of 
C57BL/6J mice
Emma K. Lees1,2, Ruth Banks1, Chelsea Cook1, Sophie Hill1, Nicola Morrice1, Louise Grant1, 
Nimesh Mody  1 & Mirela Delibegovic1
The effects of methionine restriction (MR) in rodents are well established; it leads to decreased body 
and fat mass, improved glucose homeostasis and extended lifespan, despite increased energy intake. 
Leucine restriction (LR) replicates some, but not all, of these effects of MR. To determine any differences 
in metabolic effects between MR and LR, this study compared 8 weeks of MR (80% restriction), LR 
(80% restriction) and control diet in 10-month-old C57BL/6J male mice. Body composition, food intake 
and glucose homeostasis were measured throughout the study and biochemical analyses of white 
adipose tissue (WAT) and liver were performed. MR and LR decreased body and fat mass, increased 
food intake, elevated lipid cycling in WAT and improved whole-body glucose metabolism and hepatic 
insulin sensitivity in comparison to the control diet. MR produced more substantial effects than LR on 
body mass and glucose homeostasis and reduced hepatic lipogenic gene expression, which was absent 
with the LR diet. This could be a result of amino acid-specific pathways in the liver responsible for FGF21 
stimulation (causing varied levels of FGF21 induction) and Akt activation. In summary, LR is effective at 
improving metabolic health; however, MR produces stronger effects, suggesting they activate distinct 
signalling pathways.
Methionine restriction (MR) is a dietary technique, which consistently reduces body weight and adiposity levels 
and prevents high-fat diet (HFD) -induced obesity, despite increasing food consumption, in rodents1–3. MR is 
capable of producing these effects due to its ability to enhance energy expenditure (EE), through activation of 
uncoupling protein 1 (UCP1) -dependent and UCP1-independent non-shivering thermogenesis in white adipose 
tissue (WAT) and brown adipose tissue (BAT), which elevates energy demands1.
Browning of WAT can occur after prolonged adrenergic stimulation and leads to brown-like adipocytes form-
ing in WAT, increased oxidative capacity and elevated expression of UCP14. There is evidence for MR dietary 
treatment increasing β-adrenergic stimulation and leading to browning of WAT and remodelling of lipid metab-
olism, but also enhancing lipid cycling in WAT5–8. Lipid cycling is the process of glucose being used for de novo 
lipogenesis prior to lipids being oxidised and wastes more potential energy as heat (that could be used for ATP 
synthesis), versus directly oxidising glucose9–12. This process of lipid cycling by dietary MR, together with its abil-
ity to increase UCP1 activity could explain the increased energy expenditure1.
In the liver, MR decreases lipogenesis and increases free fatty acid (FFA) oxidation5, 6, 8. Together with the 
diet’s effect to reduce triglyceride (TG) storage and decrease TG levels, it protects against fatty liver disease3, 5. 
Furthermore, MR extends lifespan in rats and mice3, 13, 14, decreases inflammation15 and improves whole-body 
glucose homeostasis and insulin sensitivity16–19. MR has been shown to have methionine-specific effects on 
hepatic insulin sensitivity by causing lower production of cysteine which is an essential precursor of glutathione 
(GSH)17. GSH activates the phosphatase; phosphatase and tensin homologue (PTEN), which degrades phosphati-
dylinositol (3,4,5)-trisphosphate (PIP3), leading to lower activation of Akt17. Therefore, with lower GSH being 
produced with the MR diet, PTEN is less active, degradation of PIP3 is reduced and downstream stimulation of 
Akt is enhanced17.
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Other essential amino acids (EAAs), apart from methionine, have been examined for their metabolic effects. 
In mice, tryptophan restriction increases lifespan20 and total amino acid restriction also extends lifespan21. 
Complete deprivation of leucine for 7 days results in body weight loss and decreased adiposity, through increased 
energy expenditure, via increased sympathetic nervous system activity and UCP1 expression in BAT22, 23. Leucine 
deprivation improves hepatic insulin sensitivity through activating general control nonderepressible 2 (GCN2), 
which reduces the inhibition of insulin receptor substrate 1 (IRS1) by the mammalian target of rapamycin 
(mTOR); therefore, enhancing downstream insulin signalling24. By activating GCN2, leucine deprivation also 
leads to induction of the hormone fibroblast growth factor 21 (FGF21) in the liver25. GCN2 senses the presence 
of uncharged transfer RNA (tRNA) and responds by phosphorylating eukaryotic initiation factor 2α (eIF2α), 
causing reduced global protein synthesis but increased transcription of activating transcription factor 4 (ATF4)25. 
ATF4 activation leads to increased transcription of FGF21 and therefore, release from the liver25. FGF21 is essen-
tial for the effects of leucine deprivation on lipid metabolism26. There is also substantial evidence for MR to 
increase FGF21 release from the liver17, 27, 28 and for the effect of MR on energy expenditure to be dependent on 
FGF2127.
FGF21 is a hormone, which regulates growth and normally is released in response to starvation by a peroxi-
some proliferator-activated receptor (PPAR) α mechanism29, 30. FGF21 induces browning of WAT, shown through 
increased expression of oxidative genes31, by signalling through the FGF receptor (FGFR) and co-receptor, β 
Klotho32. FGF21 treatment of HFD-fed mice improved glucose homeostasis and increased energy expenditure, 
leading to significant loss of body and fat mass33. In the liver, FGF21 decreases lipid accumulation through lower-
ing lipogenesis33–36 and enhancing fatty acid oxidation37.
Leucine restriction (LR) of 85% was recently examined compared to a control diet and was found to reduce 
body weight and accumulation of adipose tissue, increase food intake, improve glucose tolerance and stimulate 
hepatic induction of FGF2138. However, 85% LR did not have any effect on hepatic lipogenesis, unlike MR’s ability 
to decrease lipogenic gene expression in the liver, but it did lead to remodelling of adipose tissue38. This study 
suggests that LR produces many of the same metabolic effects as MR, but there are some differences between the 
effects produced by the diets38. It also remains to be determined whether the diets produce the same magnitude 
of effect for those effects that they have in common.
A direct comparison of methionine and leucine restriction has not previously been examined; therefore, this 
study aimed to compare 80% MR with 80% LR in order to identify the similarities and differences in metabolic 
effects and size of these effects between these two diets.
Results
MR and LR decrease body mass and alter body composition. Control-fed mice maintained a stable 
body mass throughout the course of the study, which only increased slightly by 2.3 g (Fig. 1a). However, MR- and 
LR-fed mice both significantly decreased their body mass over the course of the study, compared to control-fed 
mice (Fig. 1a). MR-fed mice decreased body mass by 8.6 g and LR-fed mice reduced body mass by 4.9 g during the 
8 week treatment, the overall effect of the diets was not significant; however, MR and LR produced a significantly 
different effect on body mass over time (Fig. 1a). After approximately 3 weeks on diet, MR produces a greater 
decline in body mass than LR (Fig. 1a). MR and LR diet-fed mice had significantly higher levels of food intake 
(adjusted for body mass) during the course of the study compared to control-fed mice, whereas there were no 
measurable differences between LR and MR (Fig. 1b). Both MR and LR significantly decreased levels of fat mass 
compared to control diet in terms of both total amount (g) and as a proportion of body mass (%) (Fig. 1c,d). LR 
and MR diets did not differ for levels of fat mass (Fig. 1c,d). Similarly, the two dietary treatments also significantly 
decreased total amount of lean mass (g) compared to control diet and MR significantly reduced lean mass (g) 
compared to LR diet; however, this was a result of losing both, fat and lean mass, but predominantly fat mass 
(Fig. 1e). This is shown in the finding of lean mass as a proportion of body mass (%) being significantly higher in 
both MR and LR diets than control diet (Fig. 1f). MR and LR diet did not produce a significantly different effect 
on proportion of lean mass (%) (Fig. 1f).
MR and LR improve whole-body glucose metabolism. We examined markers of whole-body glucose 
homeostasis by performing glucose tolerance tests (GTT) after 2 days and 5 weeks on diet, by measuring fasting 
serum insulin levels after 6 weeks on diet and by analysing fasting blood glucose at the end of the study. After just 
2 days on diet MR significantly improved glucose tolerance compared to control diet (data published previously28) 
(Fig. 2a). In comparison of MR and LR, the overall effect of the diet was not significant; however, they produced 
a significantly different effect on glucose tolerance over the 2-hour GTT (Fig. 2a). LR was unable to improve glu-
cose maintenance at this time point in comparison to control diet (Fig. 2a). These improvements by MR occurred 
before any changes in body weight/adiposity were apparent.
MR and LR both significantly improved systemic glucose clearance relative to control diet at 5 weeks of dietary 
regimen (Fig. 2b). There was no significant difference between MR- and LR-fed mice for glucose tolerance at this 
time point (Fig. 2b). By week 6 of dietary treatment MR and LR significantly decreased fasting serum insulin lev-
els relative to control diet, and MR produced significantly lower fasting serum insulin levels compared to LR diet 
(Fig. 2c). By the end of the study MR had significantly lowered fasting blood glucose levels compared to control 
diet and trended towards lower levels than LR diet (p = 0.089), whilst LR had no effect compared to control diet 
(Fig. 2d).
We also measured fasting FGF21 levels after 6 weeks on diet. MR-fed mice had significantly elevated fasting 
serum levels of FGF21 compared to LR-fed and control-fed mice (Fig. 2e). LR diet increased fasting serum levels 
of FGF21 relative to control diet, although this did not reach significance (p = 0.051) (Fig. 2e). Fasting serum 
IGF-1 levels were measured and no differences were found between any of the groups (data not shown).
www.nature.com/scientificreports/
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MR and LR increase lipogenic gene expression in epididymal WAT. In order to assess the extent 
of MR and LR effects on glucose and lipid homeostasis we used qPCR to evaluate changes in gene expression in 
epididymal WAT and liver of control-, LR- and MR-fed mice.
MR and LR significantly increased the expression of genes which promote lipogenesis; Sterol regula-
tory element binding protein 1c (Srebp1c), Acetyl CoA carboxylase (Acc) 1, Acc2, Fatty acid synthase (Fas) and 
Stearoyl-CoA desaturase 1 (Scd1) in WAT compared to control diet (Fig. 3a). There were no differences between 
MR and LR in expression of these genes in WAT, except for Srebp1c, which was significantly higher in MR than 
LR (Fig. 3a). There were no differences between any of the diets in expression levels of Pparγ, Fatty acid binding 
protein 4 (Fabp4), Leptin, β3-adrenergic receptor (Adrb3), Mitochondrial transcription factor A (Tfam), Cidea, and 
PR domain containing 16 (Prdm16) in WAT (Fig. 3a,b). Expression of PPAR gamma coactivator 1 alpha (Pgc1α) 
was increased by both MR and LR diet in WAT, but did not differ between MR and LR diet (Fig. 3a).
MR decreases lipogenic gene expression in liver. In the liver, LR decreased lipogenic gene expression 
of Pparγ compared to MR diet, but expression levels did not differ to control diet (Fig. 4a). MR diet showed no 
difference to control diet for hepatic gene expression of Pparγ (Fig. 4a). MR significantly lowered expression of 
Fas compared to both diets, but there were no differences between control and LR diet (Fig. 4a). There were no 
changes between any of the diets for expression of Srebp1c, Acc1, and Acc2 in the liver (Fig. 4a). None of the diets 
showed any differences for expression of Pgc1α, but MR significantly increased expression of Adipose triglyceride 
lipase (Atgl) compared to both diets and increased expression of Cluster of differentiation 36 (Cd36) compared 
to LR diet (Fig. 4b). LR and control diet did not differ for either of these two genes and MR and control diet 
showed no differences in expression of Cd36 (Fig. 4b). There were no differences between any of the diets for 
Phosphoenolypyruvate carboxykinase (Pepck); however, Glucose 6-phosphate (G6p) expression was significantly 
lower in MR diet than control diet (Fig. 4c). LR diet showed no differences in G6p to either control or MR diet 
Figure 1. Body mass, food intake, fat mass and lean mass of mice on MR (n = 10), LR (n = 10) and control 
(n = 9) diet. (a) Body mass (g) and (b) food intake (g/BM/day) measurements from 8 weeks of dietary 
treatment. Significance was calculated by repeated measures two-way ANOVA. *Significantly different to MR 
and LR-fed mice (P < 0.05) for overall diet effect and interaction of diet with time. #Significantly different to 
MR-fed mice (P < 0.05) for interaction of diet with time. (c) Fat mass (g), (d) fat mass (%), (e) lean mass (g), (f) 
lean mass (%) were measured after 3 weeks on diet by MRI scan in mice fed MR, LR or control diet. Significance 
was calculated by two-tailed Student’s t-test. a,bMeans with letters that differ denote significance at level of 
P < 0.05. Data are represented as mean ± SEM. White circles/bars, control-fed mice; grey circles/bars, LR-fed 
mice; black circles/bars, MR-fed mice.
www.nature.com/scientificreports/
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(Fig. 4c). None of the diets showed any differences for mRNA expression of FGF21 or Activating transcription 
factor 4 (Atf4) (Fig. 4d).
MR and LR effects on insulin signalling in epididymal WAT and liver. To assess insulin-dependent 
signalling, mice were injected with saline (154 mmol/l NaCl) or a high dose of insulin (10 mU/g body weight for 
Figure 2. Whole-body glucose homeostasis and serum FGF21 levels of mice on MR, LR or control diet. 
Glucose tolerance was assessed after (a) 2 days on diet (data presented previously for MR vs. CON28) and (b) 
5 weeks on diet by a GTT (2 g/kg) after a 5 h fast in mice fed MR (n = 10), LR (n = 10) or control (n = 9) diet. 
Significance was calculated by repeated measures two-way ANOVA. *Significantly different to MR and LR-fed 
mice (P < 0.05) for overall diet effect and interaction of diet with time. (c) Fasting serum insulin was measured 
after 6 weeks on diet, (d) fasting blood glucose was measured after 8 weeks on diet, (e) fasting serum FGF21 was 
measured after 6 weeks on diet, using tail vein blood samples taken after a 5 h fast in mice fed MR (n = 6–10), 
LR (n = 8–10) or control (n = 9) diet. Significance was calculated by two-tailed Student’s t-test. a,b,cMeans with 
letters that differ denote significance at level of P < 0.05. Data are represented as mean ± SEM. White circles/
bars, control-fed mice; grey circles/bars, LR-fed mice; black circles/bars, MR-fed mice.
Figure 3. Epididymal WAT gene expression in mice on MR (n = 9–10), LR (n = 8–10) and control (n = 7–9) 
diet. qPCR was used to measure gene expression in epididymal WAT of (a) lipogenic and adipogenic genes and 
(b) thermogenic and oxidative genes in mice fed MR, LR or control diet. Data were analysed as fold change 
relative to control-fed mice. Significance was calculated by two-tailed Student’s t-test. a,b,cMeans with letters 
that differ denote significance at level of P < 0.05. Data are represented as mean ± SEM. White bars, control-fed 
mice; grey bars, LR-fed mice; black bars, MR-fed mice.
www.nature.com/scientificreports/
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10 minutes) after a 5-h fast. Firstly, epdidymal WAT was examined. In epididymal WAT, there were no differences 
between any of the diets for protein expression of components of the insulin signalling pathway, in response to 
fasting (Fig. 5a,c). Similar results were found in response to insulin stimulation; however, MR did increase levels 
of phosphorylation of mTOR compared to control diet, but this did not reach significance (p = 0.051) (Fig. 5b,d). 
MR and LR did not differ for phosphorylation of mTOR (Fig. 5b,d). No differences were found between any of the 
diets for levels of phosphorylation of Akt or S6 in response to insulin stimulation (Fig. 5b,d).
Next, in exactly the same way as epididymal WAT, hepatic insulin signalling was examined. In the liver, both 
MR and LR significantly lowered phosphorylation of S6 under fasting conditions (Fig. 6a,c). MR and LR did 
not differ for levels of S6 phosphorylation in the liver after saline injection (Fig. 6a,c). There were no differences 
between diets for levels of phosphorylation of mTOR or Akt under fasting conditions (Fig. 6a,c). In response to 
insulin stimulation, MR-fed mice had significantly higher levels of phosphorylation of mTOR compared to both 
control and LR-fed mice and LR-fed mice trended towards higher levels of phosphorylation of mTOR relative to 
control diet (p = 0.071) (Fig. 6b,d). MR significantly decreased levels of Akt phosphorylation when exposed to 
a high dose of insulin; whereas, LR did not differ to control or MR diet (Fig. 6b,d). None of the diets differed for 
insulin-stimulated levels of phosphorylation of S6 (Fig. 6b,d).
Discussion
Dietary MR treatment decreased body mass and adiposity and increased food intake and glucose homeostasis 
in 10-month old male C7BL/6 J mice compared to control diet. These beneficial metabolic effects are consistent 
with previous studies investigating the effects of MR in young and adult rodents3, 16, 17, 19. LR also produced signif-
icantly lower body mass and fat mass and enhanced glucose homeostasis compared to the control diet. In LR-fed 
mice, it appears that food intake has been maintained at a normal level; therefore, the reduction in body mass has 
not been compensated for with a reduction in food intake. In some aspects of metabolic health that we assessed, 
Figure 4. Hepatic gene expression in mice on MR (n = 9–10), LR (n = 8–10) and control (n = 7–9) diet. qPCR 
was used to measure gene expression in the liver of (a) lipogenic genes (b) lipolytic and oxidative genes (c) 
gluconeogenic genes and (d) FGF21 and ATF4 in mice fed MR, LR or control diet. Data were analysed as fold 
change relative to control-fed mice. Significance was calculated by two-tailed Student’s t-test. a,bMeans with 
letters that differ denote significance at level of P < 0.05. Data are represented as mean ± SEM. White bars, 
control-fed mice; grey bars, LR-fed mice; black bars, MR-fed mice.
www.nature.com/scientificreports/
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MR showed a greater enhancement than LR, in particular for the reduction in body mass and lowering of serum 
insulin and blood glucose levels.
Leucine deprivation for 7 days rapidly decreased body weight and fat mass of C57BL/6 mice, probably due 
to its ability to increase energy expenditure, through elevation of thermogenic, lipolytic and oxidative genes in 
WAT22. Leucine deprivation also lowers blood glucose and serum insulin levels as well as improving hepatic 
insulin sensitivity24. Complete deprivation of leucine in the diet of mice demonstrates very similar effects on 
whole-body metabolism to LR in this study. Leucine deprivation however, is not a realistic long-term interven-
tion, as there is an increased risk of mortality with EAA deficiency, if treatment is prolonged for more than 3 
weeks8.
Fasting serum levels of FGF21 were significantly elevated by MR in comparison to both LR and control diet. 
LR also increased fasting serum FGF21 levels compared to control diet. This corresponds with previous studies 
showing leucine deprivation stimulates hepatic release of FGF21 through increased activation of GCN225.
To determine if the same pathway is responsible for MR to increase FGF21, a study using GCN2−/− mice 
delineated that MR was still able to fully phosphorylate eIF2α, increase ATF4, stimulate FGF21 release and pro-
duce its metabolic effects independently of GCN227. This was done through protein kinase R-like endoplasmic 
reticulum kinase (PERK) activation, in response to low GSH levels, rather than its commonly known stimulator 
of endoplasmic reticulum stress27. PERK also activates nuclear factor (erythroid-derived 2)-like 2 (NRF2) to pro-
duce the antioxidant response program39, which responds to low GSH levels40. This mechanism of MR to produce 
its metabolic effects through lowering GSH was shown in a study, which added cysteine to the MR diet27. This 
increased GSH and lowered serum FGF21, reversed the effects of MR on energy expenditure and serum insulin, 
as well as blocked MR’s ability to activate PERK and eIF2α and increase NRF2-sensitive and ATF4-sensitive genes 
in the liver27. Therefore, this potential divergence in FGF21-induction pathway could be the cause of the variation 
in levels of FGF21 in the serum between MR and LR.
As shown before, MR increased lipogenic gene expression in WAT, including Srebp1c, Acc1, Acc2, Fas and Scd1 
compared to the control diet5, 6, 8. LR elevated the expression levels of the same genes in epididymal WAT, relative 
to the control diet, producing similar effects to MR. MR and LR had little effect on oxidative and ‘browning’ 
genes in epididymal WAT, except for both diets increasing Pgc1α compared to control diet. This was surprising, 
as MR has previously been shown to increase sympathetic stimulation of adipose tissue1; however, there was a 
large amount of variability between mice in the current study. The increase in Pgc1α is consistent with previous 
findings of MR elevating oxidative gene expression, which, in combination with the increased lipogenesis, leads 
to lipid cycling, creating metabolic inefficiency and increased energy expenditure1, 5–8.
Figure 5. Epididymal WAT insulin signalling in mice on MR (n = 4), LR (n = 4) and control (n = 3–4) diet. 
Insulin signalling was assessed by administering either (a) saline (154 mmol/l NaCl) or (b) high dose of insulin 
(10 mU/g body weight) via i.p. injection after a 5 h fast. Levels of phosphorylated and total mTOR (s2448), Akt 
(s473) and S6 (s235/236) were measured my immunoblotting. Immunoblots were normalised to total protein 
for (c) saline condition and (d) insulin-stimulated condition. Data were analysed as fold change relative to 
control-fed mice. Significance was calculated by two-tailed Student’s t-test. a,bMeans with letters that differ 
denote significance at level of P < 0.05. Data are represented as mean ± SEM. White bars, control-fed mice; grey 
bars, LR-fed mice; black bars, MR-fed mice.
www.nature.com/scientificreports/
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In the liver, compared to control and LR diet, MR decreased lipogenic (Fas) but enhanced lipolytic (Atgl) 
gene expression, consistent with previous studies on MR, where the diet decreased hepatic lipogenesis, increased 
FA oxidation5, 6, 8 and lowered levels of stored hepatic TGs3, 5. LR, however, had no measurable effect compared 
to control diet on hepatic lipogenesis and lipolysis, consistent with previous findings of 80% LR, which con-
cluded that the effects of MR on hepatic lipid metabolism may be exclusive to methionine38. The concept of 
methionine-specific effects in the liver is in line with a previous study, which found an improvement in hepatic 
insulin sensitivity that was unique to methionine, through its effect of lowering cysteine levels17.
FGF21 treatment of diet-induced obese mice resulted in lower body weight and fat mass33. A recent study 
using FGF21−/− mice demonstrated that MR’s ability to increase energy expenditure is dependent on FGF2127. 
This dependency on FGF21 to increase energy expenditure27 and the larger rise in serum FGF21 levels with MR 
versus LR, could explain the more extensive effects on body mass by MR than LR. In addition, this could offer an 
explanation for the greater effects of MR than LR on glucose homeostasis, as FGF21 administered to diet-induced 
obese mice lowered serum insulin and blood glucose levels35 and in another study, improved whole-body glucose 
homeostasis independently of changes in body mass33.
FGF21 increases browning of WAT and has been shown to enhance the expression of Cidea, Ucp1 and Pgc1α 
after just 72 h of treatment31. FGF21 also enhances the lipid cycling process, increasing gene expression of Scd1 
and Acc35 so could explain the effects that MR and LR had in WAT. A recent study demonstrated a dose-response 
effect between LR and serum FGF21; as leucine content in the diet decreased, the levels of serum FGF21 rose, 
which paralleled the increase in UCP1 mRNA expression in WAT38. Although UCP1 was not measured in this 
study, this relationship between UCP1 and FGF21 corresponds to the relation present here between FGF21 and 
body mass loss, as UCP1 is required for MR to increase energy expenditure and, therefore, reduce body mass16.
In terms of insulin signalling, LR produced no measurable effect compared to control diet on insulin sen-
sitivity in epididymal WAT. MR produced only a small effect in response to insulin stimulation, which led to 
increased activiation of mTOR in comparison to control diet, but no effect on activation of Akt, which has been 
shown previously in epididymal WAT by MR diet28. The lack of effect on Akt may have been a result of the low 
numbers used for the immunoblotting. In vivo MR increases levels of phosphorylation of Akt in WAT, whereas in 
3T3 L1 adipocytes restricting methionine had no effect on Akt17. However, FGF21 treatment of 3T3 L1 adipocytes 
increased Akt phosphorylation, which led to the attribution of FGF21 for the effects of MR on improving WAT 
insulin sensitivity. This led to the conclusion that MR indirectly improves WAT insulin sensitivity, via circulating 
FGF21 released from the liver acting directly on WAT17. For LR, it is plausible that the increase in FGF21 was not 
sufficient enough to have an effect on WAT insulin sensitivity.
In the liver, MR and LR produced a similar response to lower activation of S6 under basal fasting conditions, 
but to increase levels of phosphorylation of mTOR under insulin stimulated conditions. MR produced a stronger 
Figure 6. Hepatic insulin signalling in mice on MR (n = 4), LR (n = 4) and control (n = 3–4) diet. Insulin 
signalling was assessed by administering either (a) saline (154 mmol/l NaCl) or (b) high dose of insulin (10 
mU/g body weight) via i.p. injection after a 5 h fast. Levels of phosphorylated and total mTOR (s2448), Akt 
(s473) and S6 (s235/236) were measured my immunoblotting. Immunoblots were normalised to total protein 
for (c) saline condition and (d) insulin-stimulated condition. Data were analysed as fold change relative to 
control-fed mice. Significance was calculated by two-tailed Student’s t-test. a,bMeans with letters that differ 
denote significance at level of P < 0.05. Data are represented as mean ± SEM. White bars, control-fed mice; grey 
bars, LR-fed mice; black bars, MR-fed mice.
www.nature.com/scientificreports/
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effect to increase mTOR phosphorylation than LR, suggesting that both diets induce enhanced hepatic insulin 
sensitivity, but with a stronger effect of the MR diet. The variation in effects between MR and LR could be due to 
the distinct mechanisms of action of the diets. It was mentioned earlier that MR has methionine-specific effects 
to increase stimulation of Akt, through lower PTEN activation in response to insulin17, which would lead to 
increased downstream signalling, including stimulation of mTOR. Similarly, LR may have leucine-specific effects, 
which have been suggested by studies on leucine deprivation24. One study reported that that under fasting condi-
tions, increased activation of GCN2 reduced activation of mTOR, leading to less inhibition of IRS124. This would 
explain the lower levels of S6 phosphorylation, a protein directly activated by mTOR24. Under opposing condi-
tions of insulin stimulation, LR induced significantly increased activation of mTOR, further adding to evidence 
for increased hepatic insulin sensitivity, in line with the effects of leucine deprivation24. These subtle distinctions 
in size of the effect on hepatic insulin sensitivity between MR and LR could play a role in the disparity of the mag-
nitude of the effect on whole body glucose metabolism between the diets.
In conclusion, this study suggests that 80% LR is an effective dietary regime for improving metabolic health; 
however, 80% MR has stronger beneficial metabolic effects on body mass reduction and improvement in glucose 
homeostasis than 80% LR. Pathways unique to a specific EAA may cause the discrepancy in the magnitude of the 
effects between MR and LR, including the mechanisms by which FGF21 is induced and Akt is activated in the 
liver.
Methods
Animals. This study was completed under UK Home Office project licence PPL 60/3951 and approved by 
the University of Aberdeen Ethics Review Board. 10-month-old male C57BL/6 J wild-type mice (Charles River, 
Edinburgh, UK) were housed in pairs. Mice were exposed to 12 h light/dark cycle at 22–24 °C and had ad libitum 
access to food and water. Mice were placed on a control diet containing 0.86% methionine, 1.11% leucine and 
2.7% glutamic acid (Dyets, Bethlehem, PA, USA) for 2 weeks. Mice were then divided evenly into three groups of 
9–10 mice, randomised by body weight and fed either control (0.86% methionine, 1.11% leucine, 2.7% glutamic 
acid), LR (0.86% methionine, 0.22% leucine, 3.70% glutamic acid) (Dyets, Bethlehem, PA, USA) or MR (0.17% 
methionine, 1.11% leucine, 3.39% glutamic acid) diet (Dyets, Bethlehem, PA, USA) for 8 weeks. The glutamic 
acid content of the MR and LR diets was increased to compensate for the reduced methionine or leucine content, 
to allow for consistent amounts of total amino acids across all diets, as done previously1, 2, 4, 16, 17, 29, 40. Glutamic 
acid was used because it makes up the highest proportion in the diet among all amino acids (Dyets, Bethlehem, 
PA, USA). Moreover, the majority of dietary glutamate (95%) is used for energy production in the intestine41; 
therefore, it was deemed to be the least likely of all the amino acids to have any physiological effect. After 8 weeks 
on diet mice were fasted for 5 h, blood glucose was measured using a glucometer (AlphaTRAK, Berkshire, UK) 
and then the mice received an intraperitoneal (i.p.) injection with saline (154 mmol/l NaCl) or a high dose of 
insulin (10 mU/g body weight) and were sacrificed 10 min-post injection. After cervical dislocation, tissues were 
immediately dissected and frozen in liquid nitrogen.
Whole- body measurements and blood metabolites. Throughout the study body weight and food 
intake were measured weekly. Body composition (fat and lean mass) was measured after 3 weeks on diet by mag-
netic resonance imaging (MRI) scan (Echo MRI, Houston, TX, USA). The machine was first equilibrated with a 
phantom mouse. The mouse was then placed into a tube and contained with a second tube to allow for only small 
movements of the mouse and accurate scanning. The results of the scanning included fat mass, lean mass and 
water content.
Glucose tolerance was assessed after 2 days and after 5 weeks on diet by a GTT. For these measurements, mice 
were fasted for 5 h prior to i.p. injection with glucose (2 g/kg body weight). Tail blood glucose measurements were 
taken using glucometers (AlphaTRAK, Berkshire, UK) immediately before and 15, 30, 60 and 120 min after i.p. 
injection with glucose.
Blood was collected from tail vein blood samples after 6 weeks on diet, after a 5 h fast. Serum insulin (5 µl 
serum) (Crystal Chem Downers Grove, Illinois, USA) and serum FGF21 (35 µl serum) (Millipore, Darmstadt, 
Germany) were measured from these blood samples using ELISA kits. Serum IGF-1 (10 µl serum) (R&D Systems, 
Minneapolis, MN, USA) was measured from trunk blood samples collected during dissection.
Immunoblotting. Frozen liver and epididymal WAT lysates were prepared in RIPA buffer, as described 
previously28. Proteins were separated by 4–12% SDS-PAGE and transferred to nitrocellulose membranes. 
Immunoblots were performed using antibodies from Cell Signaling Technology (Cell Signaling by NEB, Hitchin, 
UK) (unless stated otherwise) against phospho-mTOR (s2448) 2971 S; total mTOR 2972; phospho-S6 (s235/236) 
4858 S; total S6 2217 S; phospho-Akt/PKB (s473) 9271 S and total Akt/PKB A2210 (Santa Cruz, Dallas, Texas, 
USA). Proteins were visualised with enhanced chemiluminescence and quantified using Bio-1D software (Peqlab, 
Sarisbury Green, UK).
Gene expression in liver and epididymal WAT. Total RNA was isolated from frozen liver and epididy-
mal WAT using peqGOLD TriFast (Peqlab, Sarisbury Green, UK). For epididymal WAT, homogenates were cen-
trifuged and the lipid layer was removed before phase separation. cDNA was synthesised from 1ug RNA using 
bioscript cDNA synthesis kit (Bioline, London, UK). Per sample the mastermix contained 0.5 μl Oligo (dT)18, 
0.5 μl Random Hexamer, 1 μl dNTP (10 mM) mix, 4 μl 5 x RT buffer, 1 μl Ribosafe RNase Inhibitor (10 u/μl), 1 μl 
Tetro Reverse Transcriptase (200 u/μl), and the required volume of DEPC-treated water to make each sample up 
to 20 μl. Target genes were amplified by quantitative PCR (qPCR) on the LightCycler-480 (Roche, Burgess Hill, 
UK), using cDNA (2 µl), nuclease-free water (2.5 μl), combined forward and reverse gene-specific primers (0.5 μl) 
and GoTaq qPCR master mix (5 μl) (Promega, Southampton, UK). Relative mRNA levels were calculated using 
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the Pfaffl method42 and normalized to a geometric mean of three reference genes; Beta-actin, Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) and Ywhaz for the liver, and Nono, Ywhaz and Beta-actin for epididymal 
WAT.
Statistical analysis. Data are expressed as mean ± SEM. Statistical analyses were performed using repeated 
measures two-way ANOVA or by two-tailed Student’s t-test, as appropriate. The ANOVA or t-tests were per-
formed separately for each of the three comparisons (MR vs. LR, MR vs. CON, LR vs. CON). GraphPad Prism 
5 software (GraphPad Software, Inc., San Diego, California, USA) was used for analyses. P-values < 0.05 were 
considered significant.
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